TransMedics Reports Third Quarter 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/4/2026
- Wall St slides after strong jobs report bolsters hawkish Fed bets
- US nonfarm payrolls surge in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil slides on Friday, heads for weekly gain on US-Iran fight
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
TransMedics (TMDX) surges 40% after raising sales forecast
November 7, 2023 6:53 AM ESTTransMedics Group (NASDAQ: TMDX) saw its stock rise more than 40% in pre-market Tuesday trading after the organ transplant company raised its full-year sales forecast.
In addition to the improved outlook, the health-care firm reported third-quarter revenue that exceeded the average analyst... More
TransMedics Group (TMDX) surges 30% on strong revenue beat and guidance
November 6, 2023 4:21 PM ESTTransMedics Group (NASDAQ: TMDX) surges after strong Q3 revenue beat and raised FY revenue guidance:
reported Q3 EPS of ($0.78), $0.62 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $66.4 million versus the consensus estimate of $49.19 million.sees FY 2023... MoreTransMedics Group (TMDX) Q3 Revenue Beat; Raises FY Revenue Guidance
November 6, 2023 4:20 PM ESTTransMedics Group (NASDAQ: TMDX) reported Q3 EPS of ($0.78), $0.62 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $66.4 million versus the consensus estimate of $49.19 million.
GUIDANCE:
TransMedics Group sees FY2023 revenue of $222-230 million, versus prior of... More
